API Palmitoylethanolamide(PEA) pain relief benefits, reviews CAS 544-31-0
1. Palmitoylethanolamide (544-31-0) Description
Palmitoylethanolamide (PEA) is an endogenous fatty acid amide, belonging to the class of nuclear factor agonists. PEA has been demonstrated to bind to a receptor in the cell-nucleus (a nuclear receptor) and exerts a great variety of biological functions related to chronic pain and inflammation. The main target is thought to be the peroxisome proliferator-activated receptor alpha (PPAR-α). However, the presence of PEA (and other structurally related N-acylethanolamines) has been known to enhance anandamide activity by a so-called "entourage effect". Palmitoylethanolamide/PEA has been shown to have anti-inflammatory, anti-nociceptive, neuroprotective, and anticonvulsant properties.
2. Palmitoylethanolamide (544-31-0) Specifications
Product Name
| |
Chemical Name
|
Palmitoylethanolamide;
(2-Hydroxyethyl)hexadecanamide;
Hydroxyethylpalmitamide;
Palmidrol;
N-Palmitoylethanolamine;
|
Brand Name
|
No data for available
|
Drug Class
|
Amines, Pharmaceuticals, Intermediates & Fine Chemicals
|
CAS Number
|
544-31-0
|
InChIKey
|
HXYVTAGFYLMHSO-UHFFFAOYSA-N
|
Molecular Formula
|
C18H37NO2
|
Molecular Weight
|
299.499 g/mol
|
Monoisotopic Mass
|
299.50 g /mol
|
Melting Point
|
93 to 98 °C (199 to 208 °F; 366 to 371 K)
|
Boiling point
|
461.5 °C at 760 mmHg
|
Biological Half-Life
|
No Data Available
|
Color
|
White to Off-White Solid
|
Solubility
|
Chloroform (Sparingly), Methanol (Sparingly)
|
Storage Temperature
|
−20°C
|
Palmitoylethanolamide Application
|
Palmitoylethanolamide is an endogenous CB2 cannabinoid receptor agonist and selective GPR55 agonist.
|
3. Palmitoylethanolamide (544-31-0) video
https://vimeo.com/309416710
Comments
Post a Comment